BlackRock Investment Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

BlackRock Investment Management’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$147K	Buy	420 +5	+1%	+$1.83K	﹤0.01%	3249
2016 Q3	$167K	Buy	415 +3	+0.7%	+$1.53K	﹤0.01%	3250
2016 Q2	$245K	Buy	412 +404	+5,050%	+$245K	﹤0.01%	3259
2016 Q1	$4K	Hold	8	–	–	﹤0.01%	3875
2015 Q4	$5K	Hold	8	–	–	﹤0.01%	3872
2015 Q3	$4K	Hold	8	–	–	﹤0.01%	3992
2015 Q2	$5K	Buy	8 +5	+167%	+$13.8K	﹤0.01%	3968
2015 Q1	$25K	Hold	3	–	–	﹤0.01%	3398
2014 Q4	$26K	Hold	3	–	–	﹤0.01%	3415
2014 Q3	$14K	Buy	3 +1	+50%	+$5.28K	﹤0.01%	3540
2014 Q2	$16K	Sell	2 -30	-94%	-$150K	﹤0.01%	3480
2014 Q1	$169K	Buy	+32	New	+$151K	﹤0.01%	3251

Other funds holding EIGR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Investment Management's EIGR Position: Q4 2016 in Review

BlackRock Investment Management increased its Eiger BioPharmaceuticals, Inc. (EIGR) stake by 1.2% in Q4 2016, buying an estimated $1.83K and bringing the position to 420 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #3249.

BlackRock Investment Management first reported a position in EIGR in Q1 2014 and has held it in 12 quarters since. The position peaked at $245K in Q2 2016. 51 funds tracked by Wall St. Rank hold EIGR as of Q4 2016.

BlackRock Investment Management held 420 shares of Eiger BioPharmaceuticals, Inc. worth $147K as of Q4 2016.
BlackRock Investment Management bought 5 Eiger BioPharmaceuticals, Inc. shares in Q4 2016, an estimated $1.83K.
Eiger BioPharmaceuticals, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3249 holding.
BlackRock Investment Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2014 and has held it in 12 quarters since.
BlackRock Investment Management's Eiger BioPharmaceuticals, Inc. position peaked at $245K in Q2 2016.
51 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.